Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2014, Article ID 394754, 9 pages
http://dx.doi.org/10.1155/2014/394754
Case Report

Successful Management of Insulin Allergy and Autoimmune Polyendocrine Syndrome Type 4 with Desensitization Therapy and Glucocorticoid Treatment: A Case Report and Review of the Literature

1Endocrine and Metabolic Diseases Research Center, School of Medicine The University of Zulia, Maracaibo 4004, Venezuela
2Endocrinology Department, Maracaibo University Hospital (SAHUM), Maracaibo 4004, Venezuela

Received 26 August 2014; Accepted 30 October 2014; Published 19 November 2014

Academic Editor: Rajni Rani

Copyright © 2014 Joselyn Rojas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Executive summary: standards of medical care in diabetes—2014,” Diabetes Care, vol. 37, supplement 1, pp. S5–S13, 2014. View at Publisher · View at Google Scholar
  2. J.-W. Yoon and H.-S. Jun, “Autoimmune destruction of pancreatic β cells,” American Journal of Therapeutics, vol. 12, no. 6, pp. 580–591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Aguirre, J. Rojas, R. Cano, M. Villalobos, and L. Berrueta, “Diabetes mellitus tipo 1 y factores ambientales: la gran emboscada,” Revista Venezolana de Endocrinología y Metabolismo, vol. 10, pp. 122–134, 2012. View at Google Scholar
  4. T. L. van Belle, K. T. Coppieters, and M. G. von Herrath, “Type 1 diabetes: etiology, immunology, and therapeutic strategies,” Physiological Reviews, vol. 91, no. 1, pp. 79–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Schernthaner, “Immunogenicity and allergenic potential of animal and human insulins,” Diabetes Care, vol. 16, no. 3, pp. 155–165, 1993. View at Google Scholar · View at Scopus
  6. R. Patterson, M. RobertsI, and L. C. Grammer, “Insulin allergy: re-evaluation after two decades,” Annals of Allergy, vol. 64, no. 5, pp. 459–462, 1990. View at Google Scholar · View at Scopus
  7. M. K. Ghazavi and G. A. Johnston, “Insulin allergy,” Clinics in Dermatology, vol. 29, no. 3, pp. 300–305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Matheu, E. Perez, M. Hernández et al., “Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin,” Clinical and Molecular Allergy, vol. 3, article 16, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A.-Y. Lee, W.-Y. Chey, J. Choi, and J.-S. Jeon, “Insulin-induced drug eruptions and reliability of skin tests,” Acta Dermato-Venereologica, vol. 82, no. 2, pp. 114–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Bollinger, R. G. Hamilton, and R. A. Wood, “Protamine allergy as a complication of insulin hypersensitivity: a case report,” Journal of Allergy and Clinical Immunology, vol. 104, no. 2, pp. 462–465, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Teixeira Rodrigues, L. F. Chiaverini Ensina, L. Sabino Garro, L. Kase Tanno, P. Giavina-Bianchi, and A. Abilio Motta, “Human insulin allergy: four case reports,” European Annals of Allergy and Clinical Immunology, vol. 42, no. 6, pp. 221–223, 2010. View at Google Scholar · View at Scopus
  12. P. Andrade, L. Barros, and M. Gonçalo, “Type 1 Ig-E mediated allergy to human insulin, insulin analogues and beta-lactam antibiotics,” Anais Brasileiros de Dermatologia, vol. 87, no. 6, pp. 917–919, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. H. Hong, J. H. Lee, J. H. Shin et al., “Maintenance of insulin therapy by desensitization in insulin allergy patient,” Korean Diabetes Journal, vol. 32, pp. 529–531, 2008. View at Google Scholar
  14. H. Yokoyama, S. Fukumoto, H. Koyama, M. Emoto, Y. Kitagawa, and Y. Nishizawa, “Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering,” Diabetes Research and Clinical Practice, vol. 61, no. 3, pp. 161–166, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Pföhler, C. S. L. Müller, D. O. Hasselmann, and W. Tilgen, “Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report,” Journal of Medical Case Reports, vol. 2, article 283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Raubenheimer and N. S. Levitt, “Insulin allergy,” South African Medical Journal, vol. 94, no. 6, pp. 428–429, 2004. View at Google Scholar
  17. K.-N. Durand-Gonzalez, N. Guillausseau, C. Pecquet, and J.-P. Gayno, “Glargine insulin is not an alternative in insulin allergy,” Diabetes Care, vol. 26, no. 7, article 2216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Maheshwari, D. Goyal, P. Desouza, and R. K. Goyal, “Spotted dermopathy in a diabetic patient due to insulin allergy,” Journal of Association of Physicians of India, vol. 52, pp. 926–927, 2004. View at Google Scholar · View at Scopus
  19. Y. Q. Chu, L. J. Cai, D. C. Jiang, D. Jia, S. Y. Yan, and Y. Q. Wang, “Allergic shock and death associated with protamine administration in a diabetic patient,” Clinical Therapeutics, vol. 32, no. 10, pp. 1729–1732, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. “Insulin detemir/insulin glargine/insulin protamine aspart,” Reactions Weekly, no. 1412, p. 26, 2012.
  21. E. Alfadhli, “Allergy to insulin glargine: a case report,” Journal of Medical Cases, vol. 2, pp. 4–6, 2011. View at Google Scholar
  22. A. Sola-Gazagnes, C. Pecquet, J. M'Bemba, E. Larger, and G. Slama, “Type I and type IV allergy to the insulin analogue detemir,” The Lancet, vol. 369, no. 9562, pp. 637–638, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Darmon, V. Castera, M.-C. Koeppel, C. Petitjean, and A. Dutour, “Type III allergy to insulin detemir,” Diabetes Care, vol. 28, no. 12, article 2980, 2005. View at Google Scholar · View at Scopus
  24. B. J. Wheeler and B. J. Taylor, “Successful management of allergy to the insulin excipient metacresol in a child with type 1 diabetes: a case report,” Journal of Medical Case Reports, vol. 6, article 263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. E. R. Silva, M. J. M. Mendes, M. J. M. Ursich et al., “Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient,” Diabetes Research and Clinical Practice, vol. 36, no. 2, pp. 67–70, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Eguíluz-Gracia, M. Rodríguez-Álvarez, M. Cimarra-Álvarez, M. C. Sanabria-Pérez, and C. Martínez-Cócera, “Desensitization for Insulin allergy: a useful treatment also for local forms,” Journal of Investigational Allergology and Clinical Immunology, vol. 22, no. 3, pp. 215–235, 2012. View at Google Scholar · View at Scopus
  27. R. Begum, Y. S. Marfatia, N. C. Laddha, M. Dwivedi, M. S. Mansuri, and M. Singh, “Vitiligo: a complex disease and a complex approach,” Molecular Cytogenetics, vol. 7, article I57, 2014. View at Publisher · View at Google Scholar
  28. N. Karsli, C. Akcali, O. Ozgoztasi, N. Kirtak, and S. Inaloz, “Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy,” Journal of International Medical Research, vol. 42, pp. 799–805, 2014. View at Google Scholar
  29. B. X. Zhang, M. Lin, X. Y. Qi et al., “Characterization of circulating CD8+T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo,” European Journal of Dermatology, vol. 23, no. 3, pp. 331–338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. van den Driessche, V. Eenkhoorn, L. van Gaal, and C. de Block, “Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review,” Netherlands Journal of Medicine, vol. 67, no. 11, pp. 376–387, 2009. View at Google Scholar · View at Scopus
  31. G. J. Kahaly, “Polyendocrine autoimmune syndromes,” European Journal of Endocrinology, vol. 61, pp. 11–20, 2009. View at Google Scholar
  32. G. Petrovski, M. Zivkovic, T. Milenkovic, I. Ahmeti, and I. Bitovska, “Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine,” Acta Diabetologica, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Hasselmann, C. Pecquet, E. Bismuth et al., “Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy,” Diabetes & Metabolism, vol. 39, no. 2, pp. 174–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. P. Aujero, S. Brooks, N. Li, and S. Venna, “Severe serum sickness-like type III reaction to insulin detemir,” Journal of the American Academy of Dermatology, vol. 64, no. 6, pp. e127–e128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ghosh, V. McCann, L. Bartle, A. Collier, and I. Malik, “Allergy to insulin detemir,” Diabetic Medicine, vol. 24, no. 11, p. 1307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Takatsuki, H. Ishii, T. Yamauchi et al., “A case of insulin allergy: the crystalline human insulin may mask its antigenicity,” Diabetes Research and Clinical Practice, vol. 12, no. 2, pp. 137–139, 1991. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Blanco, R. Castillo, J. Quiralte et al., “Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 51, no. 6, pp. 421–424, 1996. View at Google Scholar · View at Scopus
  38. M. A. Mollar-Puchades and I. L. Villanueva, “Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs,” Diabetes Research and Clinical Practice, vol. 83, no. 1, pp. e21–e22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Heinzerling, K. Raile, H. Rochlitz, T. Zuberbier, and M. Worm, “Insulin allergy: clinical manifestations and management strategies,” Allergy, vol. 63, no. 2, pp. 148–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. F. Madero, J. Sastre, J. Carnés, S. Quirce, and J. L. Herrera-Pombo, “IgG4-mediated allergic reaction to glargine insulin,” Allergy, vol. 61, no. 8, pp. 1022–1023, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Asai, M. Yoshida, and Y. Miura, “Immunologic tolerance to intravenously injected insulin,” The New England Journal of Medicine, vol. 354, no. 3, pp. 307–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. V. M. Cambuli, M. Incani, E. Cossu et al., “Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children,” Diabetes Care, vol. 33, no. 4, pp. 820–822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Bruni, P. Barolo, G. Gadaleta et al., “HLA typing and insulin antibody production in insulin-dependent diabetics,” Annali dell’Ospedale Maria Vittoria di Torino, vol. 27, no. 7–12, pp. 185–213, 1984. View at Google Scholar · View at Scopus
  44. C. R. Kahn, D. Mann, A. S. Rosenthal, J. A. Galloway, A. H. Johnson, and N. Mendell, “The immune response to insulin in man. Interaction of HLA alloantigens and the development of the immune response,” Diabetes, vol. 31, no. 8, pp. 716–723, 1982. View at Publisher · View at Google Scholar · View at Scopus
  45. R. L. Mandelcorn-Monson, N. H. Shear, E. Yau et al., “Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients,” Journal of Investigative Dermatology, vol. 121, no. 3, pp. 550–556, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Bouayad, L. Benzekri, S. Hamada, C. Brick, B. Hassam, and M. Essakalli, “Association of HLA alleles and haplotypes with vitiligo in Moroccan patients: a case-control study,” Archives of Dermatological Research, vol. 305, no. 10, pp. 925–932, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Singh, P. Sharma, H. K. Kar et al., “HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo,” The Journal of Investigative Dermatology, vol. 132, no. 1, pp. 124–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. P. van Endert, Y. Hassainya, V. Lindo et al., “HLA class I epitope discovery in type 1 diabetes,” Annals of the New York Academy of Sciences, vol. 1079, pp. 190–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer, “Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms,” Endocrine Reviews, vol. 29, no. 6, pp. 697–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. H.-W. Lee, K.-B. Hahm, J. S. Lee, Y.-S. Ju, K. M. Lee, and K. W. Lee, “Association of the human leukocyte antigen class II alleles with chronic atrophic gastritis and gastric carcinoma in Koreans,” Journal of Digestive Diseases, vol. 10, no. 4, pp. 265–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Oksanen, K. E. Haimila, H. I. K. Rautelin, and J. A. Partanen, “Immunogenetic characteristics of patients with autoimmune gastritis,” World Journal of Gastroenterology, vol. 16, no. 3, pp. 354–358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Thomsen, F. Jørgensen, M. Brandsborg et al., “Association of pernicious anemia and intrinsic factor antibody with HLA-D,” Tissue Antigens, vol. 17, no. 1, pp. 97–103, 1981. View at Google Scholar · View at Scopus
  53. R. Krysiak, I. Kobielusz-Gembala, and B. Okopień, “Atypical clinical presentation of autoimmune polyglandular syndrome type 4,” Przegla̧d Lekarski, vol. 68, no. 6, pp. 339–341, 2011. View at Google Scholar · View at Scopus
  54. Y.-T. Hsu, J.-R. Duann, M.-K. Lu, M.-C. Sun, and C.-H. Tsai, “Polyglandular autoimmune syndrome type 4 with GAD antibody and dystonia,” Clinical Neurology and Neurosurgery, vol. 114, no. 7, pp. 1024–1026, 2012. View at Publisher · View at Google Scholar · View at Scopus